BGM Group/$BGM
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About BGM Group
BGM Group Ltd is a biopharmaceuticals, bio-extraction, and medical health business. Its product range includes oxytetracycline APIs, licorice preparations, and crude heparin sodium. Maximum revenue is from Oxytetracycline & Licorice and TCMD, followed by Heparin products and Sausage casing.
Ticker
$BGM
Sector
Primary listing
Employees
-
Headquarters
Website
BGM Group Metrics
BasicAdvanced
$104m
-
-$0.18
-
-
Price and volume
Market cap
$104m
52-week high
$11.80
52-week low
$0.25
Average daily volume
291k
Financial strength
Current ratio
1.239
Quick ratio
0.432
Long term debt to equity
0.02
Total debt to equity
0.495
Profitability
EBITDA (TTM)
-11.118
Gross margin (TTM)
16.64%
Net profit margin (TTM)
-52.59%
Operating margin (TTM)
-33.18%
Effective tax rate (TTM)
-1.39%
Management effectiveness
Return on assets (TTM)
-3.23%
Return on equity (TTM)
-9.27%
Valuation
Price to revenue (TTM)
0.812
Price to book
0.14
Price to tangible book (TTM)
1.49
Price to free cash flow (TTM)
-6.752
Free cash flow yield (TTM)
-14.81%
Free cash flow per share (TTM)
-0.04
Growth
Revenue change (TTM)
51.09%
Earnings per share change (TTM)
-10.00%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.